Zacks.com on MSN
BDX Introduces BD Research Cloud 7.0 for Advanced Flow Cytometry
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the global commercial launch of BD Research Cloud 7.0, marking another step forward in its AI-driven life sciences strategy ...
Zacks.com on MSN
BD Merges Biosciences & Diagnostics Business With Waters
Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has completed the previously disclosed spin-off of its Biosciences & Diagnostic business, followed by the merger of ...
Zacks Investment Research on MSN
BD & Envetec showcase closed-loop recycling solution for lab plastics
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the successful completion of a joint feasibility ...
Zacks Investment Research on MSN
BD gets FDA 510(k) approval for EnCor EnCompass breast biopsy system
Becton, Dickinson and CompanyBDX, popularly known as BD, recently announced that the FDA has granted 510(k) clearance for its EnCor EnCompass Breast Biopsy and Tissue Removal System. Anticipated to ...
Flow cytometry is a crucial technique for many scientists because it allows them to rapidly detect, sort and analyse cells with particular characteristics. But traditional flow cytometry can be a ...
Antibody-drug conjugates (ADCs) represent a powerful therapeutic modality for solid tumors and hematological malignancies. However, their development is often challenged by limited translational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results